Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00752_DB00918_nanopub.RAMAxId2O7KneU3qTYLcNN-_9bedbB8IANxfbq4bDi3bE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00752_DB00918 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00752_DB00918 label "DDI between Tranylcypromine and Almotriptan - The MAO inhibitor, Tranylcypromine, may reduce the metabolism and clearance of the serotonin 5-HT1D receptor agonist, Almotriptan. Risk of serotonin syndrome and Almotriptan toxicity. Concomitant therapy should be avoided. [drugbank_resource:DB00752_DB00918]" assertion.
- drugbank_resource:DB00752_DB00918 identifier "drugbank_resource:DB00752_DB00918" assertion.
- drugbank_resource:DB00752_DB00918 title "DDI between Tranylcypromine and Almotriptan - The MAO inhibitor, Tranylcypromine, may reduce the metabolism and clearance of the serotonin 5-HT1D receptor agonist, Almotriptan. Risk of serotonin syndrome and Almotriptan toxicity. Concomitant therapy should be avoided." assertion.
- drugbank:DB00918 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00752_DB00918 assertion.
- drugbank:DB00752 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00752_DB00918 assertion.